| Document |
Document Title |
|
WO/2024/030919A1 |
Provided herein are methods and systems for sequencing proteins. One or more methods disclosed herein may use linkers comprising an amino acid-reactive group and an additional reactive moiety that may be used to couple a polymerizable mo...
|
|
WO/2024/028794A1 |
The disclosure provides for methods and compositions that target the interaction of αV/β1 integrin and monomeric MPO in ovarian cancer and other hyperproliferative disorders. Accordingly, aspects of the disclosure relate to a method fo...
|
|
WO/2024/029565A1 |
Provided is a wearable sensor capable of monitoring sweat components and body surface temperature and/or body fluid temperature at high accuracy in real time. The present invention relates to a wearable sensor that includes: a base mat...
|
|
WO/2024/027667A1 |
The present application provides a detection assembly for medical detection equipment, and medical detection equipment. The detection assembly comprises a shell and a detection electrode. The shell is provided with a top surface, a botto...
|
|
WO/2024/029992A1 |
The present invention relates to a peptide capable of directly binding to amyloid beta protein Aβ42, which is known to be a causative agent of Alzheimer's disease, and a composition for the treatment and prevention of Alzheimer's diseas...
|
|
WO/2024/029082A1 |
The present invention acquires an image of an immunochromatographic test piece (S1), sets a rectangular detection window including one colored region in the image (S2), and determines a hue value range Hmin- Hmax in which the colored reg...
|
|
WO/2024/027835A1 |
Provided is an antibody targeting EGFRvIII or an antigen-binding fragment thereof. Further provided are a CAR comprising the antigen-binding fragment targeting EGFRvIII, and treatment and detection use thereof.
|
|
WO/2024/029737A1 |
An automatic blood viscosity measurement device according to an embodiment of the present invention includes: a housing including an opening door provided therein; a blood sample mounting part in which a blood collection tube is mounted;...
|
|
WO/2024/030982A2 |
The present invention relates to a lateral flow test device capable of detecting the presence or absence of unfolded p53 in a liquid sample, such as a blood sample. Also provided are methods of using such a device for quantitative or qua...
|
|
WO/2024/026961A1 |
A portable intelligent low-disturbance sampling apparatus, comprising a power supply device (1), a low-disturbance water pumping device, a packer device, a downhole monitoring device, a true value determination and sampling device (2), a...
|
|
WO/2024/028470A1 |
A method of forming a particulate probe, the method comprising the steps of: providing a biomolecule; providing a particulate light-emitting marker comprising at least one azide group at a surface thereof; providing a linker, the linker ...
|
|
WO/2024/030571A1 |
The present disclosure advantageously refers to systems and methods for predicting an oil mixture's blend compatibility without mixing the components and/or without performing direct blend testing. The techniques described use a correlat...
|
|
WO/2024/028876A1 |
The invention provides aminochalcone -diacetylene compound of Formula 1A: wherein R1 and R2 are independently selected from H and C1-C3 alkyl, A denotes a linkage connecting the chalcone and diacetylene units, m and n are independently i...
|
|
WO/2024/026855A1 |
A neutralizing antibody period reading and measurement method based on a rapid screening test strip, comprising the steps of: step one (200): providing a screening test strip (20), having a screening test strip reaction area (21), wherei...
|
|
WO/2024/030431A1 |
A biological test system has receptacles for a variety of removable electro-mechanical biological blood test-based elements having multiple features such as lancets or strips. Testing is through an analysis biological test processor that...
|
|
WO/2024/030011A1 |
The present disclosure relates to a miniaturized gas sensor that can be used as a gas detector and/or air quality monitor. It relates in particular to a hybrid gas sensor based on the combination of infrared and semiconductor metal oxide...
|
|
WO/2024/030024A1 |
The present invention provides methods for detecting an anti-Schistosoma antibody in a sample obtained from a subject. Corresponding compounds, compositions, kits and methods for monitoring a subject to determine if they have contracted ...
|
|
WO/2024/030499A1 |
A system for in vitro molecular diagnostic of an analyte is described. The system includes a test kit and a diagnostic device. The system provides automatic conveyance of kit information to the diagnostic device, including diagnostic pro...
|
|
WO/2024/027496A1 |
The present application provides a blood gas analysis device, comprising a first measurement assembly and a kit. The first measurement assembly is provided with a measurement element, a first liquid path, and a first interface, the first...
|
|
WO/2024/027084A1 |
A construction method for a rock mechanics parameter evaluation model, and a rock mechanics property evaluation method. The construction method comprises: constructing a three-dimensional rock core numerical model group, which includes a...
|
|
WO/2024/027020A1 |
A rigidity and flexibility test device for a rigid-flexible transition busbar and a test method thereof. The rigidity and flexibility test device comprises a moving vehicle (9) capable of moving in the length extending direction of a rig...
|
|
WO/2024/030857A1 |
Provided are assays that can provide the percentage of a first mammalian cell population (e.g., human cells) compared to a second mammalian cell population (e.g. mouse cells) in a mixed cell sample. The assays can be used to, for example...
|
|
WO/2024/029124A1 |
Disclosed are a method, a device, and an information processing program for determining, by using refractive index distribution data pertaining to an object to be observed, the region of a cell that has undergone programmed cell death in...
|
|
WO/2024/030680A1 |
Disclosed are methods and systems for evaluating various health markers to distinguish various health risks. In one embodiment, the method comprises evaluating biomarkers to determine a relative risk of premature all-cause mortality in m...
|
|
WO/2024/030909A1 |
This disclosure provides biomarkers for assessing response to a therapy for post-acute sequelae of COVID-19 (PASC). In some embodiments, the biomarker comprises NfL, IL-26, Activin, GPX3, GSR, FGF21, or VCAM1.
|
|
WO/2024/030525A1 |
Embodiments presented provide for a method of evaluation for data that is inconsistent or that changes over time. These embodiments involve the processing of pollutants in a stream such that accuracy is maintained during the processing f...
|
|
WO/2024/028088A1 |
The invention relates to a method for introducing a biological sample, to be concentrated, containing biological material into a centrifugal microfluidic cartridge (15) and subsequently analysing the biological sample by means of a centr...
|
|
WO/2024/029439A1 |
This burying environment classification map creation device (second burying environment classification map creation unit (63)) comprises: a first soil identification unit (63a) that identifies groundwater permeable soils, which are soils...
|
|
WO/2024/028731A1 |
Provided are novel multispecific antibodies comprising at least one of a first antigen-binding region and a second antigen-binding region each capable of binding specifically to human epidermal growth factor receptor 2 (HER2), and a thir...
|
|
WO/2024/030452A1 |
MRV for an ocean CDR system is achieved by varying the release/delivery of base substance into ocean seawater such that the base substance propagates as a series of release batch wavefronts along a dispersion path. A release frequency, w...
|
|
WO/2024/029678A1 |
The present invention relates to a use of PDH inhibitors in the treatment of neurodegenerative diseases, and according to the present invention, in a DJ-1 deletion Parkinson's disease Drosophila model, by activation of PDK, promotion of ...
|
|
WO/2024/029535A1 |
The present invention provides a polypeptide that specifically recognizes a structurally abnormal protein caused by misfolding, etc. in mammals, and a detection agent and a reduction agent for a structurally abnormal protein with the use...
|
|
WO/2024/026578A1 |
The invention relates to an antibody for detecting the presence of the fungus Chondrostereum purpureum in a plant sample, which has a heavy chain defined by amino acid sequence SEQ ID NO. 2 and a light chain defined by amino acid sequenc...
|
|
WO/2024/028602A1 |
An interferometric optical sensor system for use in optical sensing of a target substance comprises an optical sensor element, an optical source, a polarisation control arrangement and an image sensor. The optical sensor element comprise...
|
|
WO/2024/028436A1 |
The present invention relates to the identification of novel therapeutic targets and their use in the mitigation of inflammatory pathologies. In particular, the present invention concerns the field of anti-interleukin-17A antibodies, pha...
|
|
WO/2024/027409A1 |
A grouting simulation experiment apparatus and method under variable stratum conditions. The apparatus comprises a storage cylinder (4), wherein the storage cylinder (4) extends into a simulation slot (3); the simulation slot (3) is prov...
|
|
WO/2024/027599A1 |
The present invention provides use of IL-1 alpha, IL-4, IL-18, IL-27a, EGF, HGF, VEGF-D, SCF, IFN-gamma, and MCP-1 (CCL2) or CCL11 (Eotaxin) in blood samples and CD8, CD3&CD8 and CD3&CD8&PD-1 in tumor tissue samples of a rectal cancer pa...
|
|
WO/2024/028653A1 |
The disclosure provides methods for identifying a therapeutic for treatment of heart failure with preserved ejection fraction. The method may comprise contacting cardiac tissue or a cardiac organoid with an effective amount of Transformi...
|
|
WO/2024/030346A1 |
The present disclosure provides a system and method for AI-based cell classification of cells from a patient sample to determine if cells indicative of lung cancer are present. In the system and method, 2D imaging is used to eliminate ce...
|
|
WO/2024/030957A1 |
The present disclosure relates to implantable constructs designed to deliver therapeutic reagents to a subject for the induction of tissue regeneration in damaged or disease lung and heart tissues. In certain aspects, the constructs are ...
|
|
WO/2024/026672A1 |
A method and a system (400) for predicting odor of an aqueous polymer composition, such as a polymerising coating, comprising: analytically characterizing the aqueous polymer composition with a detector (4013), thereby generating concent...
|
|
WO/2024/029995A1 |
The present invention relates to a peptide capable of directly binding to amyloid beta protein Aβ42, known to be a causative agent of Alzheimer's disease, and a composition for treating and preventing Alzheimer's disease, comprising the...
|
|
WO/2024/028620A2 |
Selective fluorescent probes for measuring multidrug transporter activity The present invention relates to a fluorescent dye accumulation assay for parallel measurements of ABC multidrug transporters, as efflux pump, capable of extruding...
|
|
WO/2024/029523A1 |
The present invention addresses the problem of providing information for assessing evaluation items for assessing the necessity of vaccination for coronavirus diseases, identifying high-risk persons who could become severely ill due to i...
|
|
WO/2024/030503A1 |
Systems, methods for producing antibodies are disclosed. A method for increasing IgY in a bird egg includes exposing a bird to one or more antigens where the exposing is performed on at least two separate occurrences and where a time bet...
|
|
WO/2024/028276A1 |
The invention relates to methods for determining the prognosis of a patient suffering colorectal cancer, for selecting an adjuvant chemotherapy for said patient and for selecting a patient suffering colorectal cancer to receive adjuvant ...
|
|
WO/2024/029625A1 |
This medicine contains, as an active ingredient, an ETS1 inhibitor that inhibits the expression or function of ETS Proto-Oncogene 1, Transcription Factor (ETS1) in a fibroblast-specific manner.
|
|
WO/2024/028451A1 |
A method of additively manufacturing a sensor is provided. The method comprises providing a working electrode and a reference electrode, wherein the reference electrode and the working electrode comprises a conductive agent composition; ...
|
|
WO/2024/028732A1 |
Provided are novel multispecific antibodies comprising at least one of a first antigen-binding region and a second antigen-binding region each capable of binding specifically to human epidermal growth factor receptor 2 (HER2), and a thir...
|
|
WO/2024/028217A1 |
The invention relates to a method and a gas sensor for ascertaining the concentration of a gas component in a gas mixture. The gas sensor (100) comprises a heating device (110), which is designed to heat the gas mixture, and a temperatur...
|
